» Articles » PMID: 1322866

Beneficial Health Effects of Modest Weight Loss

Overview
Date 1992 Jun 1
PMID 1322866
Citations 288
Authors
Affiliations
Soon will be listed here.
Abstract

The medical effects of modest weight reduction (approximately 10% or less) in patients with obesity-associated medical complications were reviewed. The National Library of Medicine MEDLINE database and the Derwent RINGDOC database were searched to identify English language studies that examined the effects of weight loss in obese patients with serious medical complications commonly associated with obesity (non-insulin dependent diabetes mellitus (NIDDM or type II), hypertension, hyperlipidemia, hypercholesterolemia, and cardiovascular disease). Studies in which patients experienced approximately 10% or less weight reduction were selected for review. Studies indicated that, for obese patients with NIDDM, hypertension or hyperlipidemia, modest weight reduction appeared to improve glycemic control, reduce blood pressure, and reduce cholesterol levels, respectively. Modest weight reduction also appeared to increase longevity in obese individuals. In conclusion, a large proportion of obese individuals with NIDDM, hypertension, and hyperlipidemia experienced positive health benefits with modest weight loss. For patients who are unable to attain and maintain substantial weight reduction, modest weight loss should be recommended; even a small amount of weight loss appears to benefit a substantial subset of obese patients.

Citing Articles

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study.

Ard J, Ryan D, ONeil P, Kushner R, Wyatt H, Bays H Obesity (Silver Spring). 2025; 33(3):500-511.

PMID: 39904726 PMC: 11897854. DOI: 10.1002/oby.24240.


Factors influencing adherence to dietary recommendations for type 2 diabetes mellitus and their impact on disease control: A cross-sectional study.

Patel H, Unadkat S, Patel B, Parmar D J Family Med Prim Care. 2025; 13(12):5648-5654.

PMID: 39790796 PMC: 11709071. DOI: 10.4103/jfmpc.jfmpc_776_24.


Long-term weight loss and cardiorenal outcomes by baseline BMI in the VERTIS CV trial.

Cosentino F, Dagogo-Jack S, Frederich R, Cannon C, Cherney D, Mancuso J Diabetes Obes Metab. 2024; 27(2):583-594.

PMID: 39696829 PMC: 11701189. DOI: 10.1111/dom.16050.


8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2025.

Diabetes Care. 2024; 48(Supplement_1):S167-S180.

PMID: 39651976 PMC: 11635032. DOI: 10.2337/dc25-S008.


The Fully Understanding Eating and Lifestyle Behaviors (FUEL) trial: Protocol for a cohort study harnessing digital health tools to phenotype dietary non-adherence behaviors during lifestyle intervention.

Goldstein S, Mwenda K, Hoover A, Shenkle O, Jones R, Thomas J Digit Health. 2024; 10:20552076241271783.

PMID: 39175923 PMC: 11339753. DOI: 10.1177/20552076241271783.